Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

ASCO Clinical Practice Guideline Endorsements and Adaptations

View through CrossRef
ASCO engages in the endorsement and adaptation of clinical practice guidelines to recognize the high-quality work of other guideline-developing organizations, to avoid duplication of effort, and to offer harmonized recommendations across guideline development groups. ASCO develops guidelines in accordance with the principles of the National Academy of Medicine and Council of Medical Specialty Societies. Guidelines developed in a similar manner by other organizations make endorsement by ASCO more likely. If allowed by the partnering organization, ASCO may consider an adaptation of a guideline, building on the original guideline with further inquiry or modifications. Organizations seeking ASCO endorsement consideration are provided with ASCO’s endorsement and adaptation procedures at the time of endorsement submission They can request either Endorsement or Endorsement or Adaptation. ASCO endorsement entails a formal review by an independent ASCO Expert Panel, and, if modifications to the recommendations are made, depending upon the original endorsement request, guidelines will be adapted or discontinued, rather than endorsed. The process begins with approval from ASCO’s Clinical Practice Guideline Committee (CPGC) leadership to proceed with endorsement development. An ASCO Expert Panel of approximately 10 multidisciplinary content experts, patient representatives, community oncologists, and relevant health providers is formed to develop an ASCO endorsement. ASCO’s Conflict of Interest Policy Implementation for Clinical Practice Guidelines and procedures apply to all ASCO expert panels. The CPGC reviews and approves all ASCO guideline products on behalf of ASCO. The endorsement process described in this report is designed to preserve a high-quality and resource-efficient approach for potential ASCO endorsement or adaptation of guidelines developed by other health professional organizations, while maintaining the objectivity, quality, and high standards reflective of ASCO’s guiding principles.
Title: ASCO Clinical Practice Guideline Endorsements and Adaptations
Description:
ASCO engages in the endorsement and adaptation of clinical practice guidelines to recognize the high-quality work of other guideline-developing organizations, to avoid duplication of effort, and to offer harmonized recommendations across guideline development groups.
ASCO develops guidelines in accordance with the principles of the National Academy of Medicine and Council of Medical Specialty Societies.
Guidelines developed in a similar manner by other organizations make endorsement by ASCO more likely.
If allowed by the partnering organization, ASCO may consider an adaptation of a guideline, building on the original guideline with further inquiry or modifications.
Organizations seeking ASCO endorsement consideration are provided with ASCO’s endorsement and adaptation procedures at the time of endorsement submission They can request either Endorsement or Endorsement or Adaptation.
ASCO endorsement entails a formal review by an independent ASCO Expert Panel, and, if modifications to the recommendations are made, depending upon the original endorsement request, guidelines will be adapted or discontinued, rather than endorsed.
The process begins with approval from ASCO’s Clinical Practice Guideline Committee (CPGC) leadership to proceed with endorsement development.
An ASCO Expert Panel of approximately 10 multidisciplinary content experts, patient representatives, community oncologists, and relevant health providers is formed to develop an ASCO endorsement.
ASCO’s Conflict of Interest Policy Implementation for Clinical Practice Guidelines and procedures apply to all ASCO expert panels.
The CPGC reviews and approves all ASCO guideline products on behalf of ASCO.
The endorsement process described in this report is designed to preserve a high-quality and resource-efficient approach for potential ASCO endorsement or adaptation of guidelines developed by other health professional organizations, while maintaining the objectivity, quality, and high standards reflective of ASCO’s guiding principles.

Related Results

Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Us Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Treating Tobacco Use and Dependence, a Public Health Service-sponsored Clinical Practice Guideline, is a product of the Tobacco Use and Dependence Guideline Panel ("the panel"), co...
Perception of consumers toward celebrity endorsements of students at Nueva Ecija University of Science and Technology, San Isidro Campus
Perception of consumers toward celebrity endorsements of students at Nueva Ecija University of Science and Technology, San Isidro Campus
Background and objectives: Celebrity endorsements have emerged as a common tactic in marketing and advertising that manipulates the fame and influence of well-known people to promo...
Commentary on the NICE guideline on renal replacement therapy and conservative management
Commentary on the NICE guideline on renal replacement therapy and conservative management
Abstract Background NICE Guideline NG107, “Renal replacement therapy and conservative management” (Renal replacement therapy and conservative manage...
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
AimsRecent conclusive evidence has suggested that, contrary to previous limited evidence, there is no benefit to the use of 3% hypertonic saline (3% HS) in the treatment of bronchi...
Abstract 1566: Guideline-concordant care among women with HER2 negative metastatic breast cancer: A SEER-Medicare analysis
Abstract 1566: Guideline-concordant care among women with HER2 negative metastatic breast cancer: A SEER-Medicare analysis
Abstract Objectives: Limited data exist regarding the rates of guideline-concordant care among women with HER2 negative metastatic breast cancer (MBC). The primar...
Interview: Kari Tikkinen
Interview: Kari Tikkinen
What initially sparked your interest in medicine, and what led you specifically to the field of urology? I was not sure about medicine until I was almost 20. In high school I was t...
Genetic adaptations in the population history of Arabidopsis thaliana
Genetic adaptations in the population history of Arabidopsis thaliana
The Arabidopsis thaliana population has been exposed to unexperienced biotic and abiotic stresses as a result of range expansion or environmental change. To obtain a global picture...

Back to Top